Teva India Profile
Key Indicators
- Authorised Capital ₹ 18.43 Cr
as on 23-10-2024
- Paid Up Capital ₹ 12.56 Cr
as on 23-10-2024
- Company Age 24 Year, 7 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -83.07%
(FY 2023)
- Profit -87.45%
(FY 2023)
- Ebitda 60.81%
(FY 2023)
- Net Worth 4.10%
(FY 2023)
- Total Assets 3.24%
(FY 2023)
About Teva India
The Corporate was formerly known as Ivax India Private Limited. The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 18.43 Cr and a paid-up capital of Rs 12.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Teva India Private Limited India is Raghav Agiwal as COMPANY SECRETARY. Fabian Dsouza and Nishank Bhargava serve as directors at the Company.
- CIN/LLPIN
U73100MH2000PTC405989
- Company No.
268473
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2000
- Date of AGM
23 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Teva India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raghav Agiwal | Company Secretary | 01-Jul-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishank Bhargava  | Director | 28-Mar-2022 | Current |
| Fabian Dsouza | Director | 26-Jul-2016 | Current |
Financial Performance and Corporate Structure Insights of Teva India.
Teva India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 83.07% decrease. The company also saw a substantial fall in profitability, with a 87.45% decrease in profit. The company's net worth moved up by a moderate rise of 4.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Teva India?
In 2023, Teva India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Teva Pharmaceutical And Chemical Industries India Private LimitedActive 21 years 7 monthsNishank Bhargava is a mutual person
Actavis Pharma Development Centre Private LimitedActive 18 years 4 monthsNishank Bhargava is a mutual person
Teva Global Business Services Private LimitedActive 20 years 4 monthsNishank Bhargava is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Teva India?
Teva India has a workforce of 16 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Teva India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Teva India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
